graft

(redirected from arteriovenous graft)
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.

Graft

A colloquial term referring to the unlawful acquisition of public money through questionable and improper transactions with public officials.

Graft is the personal gain or advantage earned by an individual at the expense of others as a result of the exploitation of the singular status of, or an influential relationship with, another who has a position of public trust or confidence. The advantage or gain is accrued without any exchange of legitimate compensatory services.

Behavior that leads to graft includes Bribery and dishonest dealings in the performance of public or official acts. Graft usually implies the existence of theft, corruption, Fraud, and the lack of integrity that is expected in any transaction involving a public official.

graft

noun blackmail, bribery, corruption, fraudulent income, hush money, illegal profit, illicit profit, illicit revenue, inserere, kickback, money illegally accuired, political corruption, profiteering, property illegally acquired, unjust acquisition, unlawful gain
Associated concepts: bribery, corruption, official misconduct
See also: bribe, connect, corruption, crime, gratuity, hush money, improbity, spoils

GRAFT. A figurative term in chancery practice, to designate the right of a mortgagee in premises, to which the mortgagor at the time of making the mortgage had an imperfect title, but who afterwards obtained a good title. In this case the new mortgage is considered a graft into the old stock, and, as arising in consideration of the former title. 1 Ball & Beat. 46; Id. 40; Id. 57; 1 Pow. on Mortg. 190. See 9 Mass. 34. The same principle has obtained by legislative enactment in Louisiana. If a person contracting an obligation towards another, says the Civil Code, art. 2371, grants a mortgage on property of which he is not then the owner, this mortgage shall be valid, if the debtor should ever acquire the ownership of, the property, by whatever right.

References in periodicals archive ?
The Orphan Drug Designation is granted for the prevention of arteriovenous fistula or arteriovenous graft failure in patients with end-stage renal disease (ESRD) receiving hemodialysis or preparing for hemodialysis.
Proteon previously completed a Phase 1/2 AVF study, the results of which were recently published in the Journal of Vascular Access, and recently completed follow-up in a Phase 1/2 study in patients undergoing surgical placement of an arteriovenous graft (AVG).
PRT-201 is an investigational recombinant human elastase that is being studied for its ability to improve arteriovenous fistula (AVF) and arteriovenous graft (AVG) outcomes in patients requiring chronic hemodialysis.
PRT-201 will also be studied for its ability to improve outcomes after arteriovenous graft (AVG) surgery by prolonging the time that AVGs can be used for chronic hemodialysis without the need for corrective procedures or replacement.